Cargando…
BACH2 represses effector programmes to stabilize Treg-mediated immune homeostasis - a new target in tumor immunotherapy?
| Autores principales: | , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2013
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3991066/ http://dx.doi.org/10.1186/2051-1426-1-S1-O14 |
| _version_ | 1782312375643275264 |
|---|---|
| author | Roychoudhuri, Rahul Hirahara, Kiyoshi Mousavi, Kambiz Clever, David Bonelli, Michael Klebanoff, Christopher Sartorelli, Vittorio Kanno, Yuka Gattinoni, Luca Wang, Ena Liu, Hui Marincola, Franco Kazuhiko, Igarashi O’Shea, John Restifo, Nicholas P |
| author_facet | Roychoudhuri, Rahul Hirahara, Kiyoshi Mousavi, Kambiz Clever, David Bonelli, Michael Klebanoff, Christopher Sartorelli, Vittorio Kanno, Yuka Gattinoni, Luca Wang, Ena Liu, Hui Marincola, Franco Kazuhiko, Igarashi O’Shea, John Restifo, Nicholas P |
| author_sort | Roychoudhuri, Rahul |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-3991066 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2013 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-39910662014-05-01 BACH2 represses effector programmes to stabilize Treg-mediated immune homeostasis - a new target in tumor immunotherapy? Roychoudhuri, Rahul Hirahara, Kiyoshi Mousavi, Kambiz Clever, David Bonelli, Michael Klebanoff, Christopher Sartorelli, Vittorio Kanno, Yuka Gattinoni, Luca Wang, Ena Liu, Hui Marincola, Franco Kazuhiko, Igarashi O’Shea, John Restifo, Nicholas P J Immunother Cancer Oral Presentation BioMed Central 2013-11-07 /pmc/articles/PMC3991066/ http://dx.doi.org/10.1186/2051-1426-1-S1-O14 Text en Copyright © 2013 Roychoudhuri et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Oral Presentation Roychoudhuri, Rahul Hirahara, Kiyoshi Mousavi, Kambiz Clever, David Bonelli, Michael Klebanoff, Christopher Sartorelli, Vittorio Kanno, Yuka Gattinoni, Luca Wang, Ena Liu, Hui Marincola, Franco Kazuhiko, Igarashi O’Shea, John Restifo, Nicholas P BACH2 represses effector programmes to stabilize Treg-mediated immune homeostasis - a new target in tumor immunotherapy? |
| title | BACH2 represses effector programmes to stabilize Treg-mediated immune homeostasis - a new target in tumor immunotherapy? |
| title_full | BACH2 represses effector programmes to stabilize Treg-mediated immune homeostasis - a new target in tumor immunotherapy? |
| title_fullStr | BACH2 represses effector programmes to stabilize Treg-mediated immune homeostasis - a new target in tumor immunotherapy? |
| title_full_unstemmed | BACH2 represses effector programmes to stabilize Treg-mediated immune homeostasis - a new target in tumor immunotherapy? |
| title_short | BACH2 represses effector programmes to stabilize Treg-mediated immune homeostasis - a new target in tumor immunotherapy? |
| title_sort | bach2 represses effector programmes to stabilize treg-mediated immune homeostasis - a new target in tumor immunotherapy? |
| topic | Oral Presentation |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3991066/ http://dx.doi.org/10.1186/2051-1426-1-S1-O14 |
| work_keys_str_mv | AT roychoudhurirahul bach2represseseffectorprogrammestostabilizetregmediatedimmunehomeostasisanewtargetintumorimmunotherapy AT hiraharakiyoshi bach2represseseffectorprogrammestostabilizetregmediatedimmunehomeostasisanewtargetintumorimmunotherapy AT mousavikambiz bach2represseseffectorprogrammestostabilizetregmediatedimmunehomeostasisanewtargetintumorimmunotherapy AT cleverdavid bach2represseseffectorprogrammestostabilizetregmediatedimmunehomeostasisanewtargetintumorimmunotherapy AT bonellimichael bach2represseseffectorprogrammestostabilizetregmediatedimmunehomeostasisanewtargetintumorimmunotherapy AT klebanoffchristopher bach2represseseffectorprogrammestostabilizetregmediatedimmunehomeostasisanewtargetintumorimmunotherapy AT sartorellivittorio bach2represseseffectorprogrammestostabilizetregmediatedimmunehomeostasisanewtargetintumorimmunotherapy AT kannoyuka bach2represseseffectorprogrammestostabilizetregmediatedimmunehomeostasisanewtargetintumorimmunotherapy AT gattinoniluca bach2represseseffectorprogrammestostabilizetregmediatedimmunehomeostasisanewtargetintumorimmunotherapy AT wangena bach2represseseffectorprogrammestostabilizetregmediatedimmunehomeostasisanewtargetintumorimmunotherapy AT liuhui bach2represseseffectorprogrammestostabilizetregmediatedimmunehomeostasisanewtargetintumorimmunotherapy AT marincolafranco bach2represseseffectorprogrammestostabilizetregmediatedimmunehomeostasisanewtargetintumorimmunotherapy AT kazuhikoigarashi bach2represseseffectorprogrammestostabilizetregmediatedimmunehomeostasisanewtargetintumorimmunotherapy AT osheajohn bach2represseseffectorprogrammestostabilizetregmediatedimmunehomeostasisanewtargetintumorimmunotherapy AT restifonicholasp bach2represseseffectorprogrammestostabilizetregmediatedimmunehomeostasisanewtargetintumorimmunotherapy |